A new study out of the United States could shift how multiple sclerosis (MS) is detected and treated. Researchers say they’ve ...

Enrollment is complete for the randomized part of ENHANCE, a Phase 3 trial testing a new dosing schedule for Briumvi in ...

Cycling for a Cure to End Multiple Sclerosis NEW BERN, NC / ACCESS Newswire / October 28, 2025 / This September, 1,200 cyclists and hundreds of volunteers took part in Bike MS: Historic New Bern Ride, ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

Lou Gehrig's disease, also known as amyotrophic lateral sclerosis (ALS), affects about 30,000 people in the US, and leads ...

Telehealth-based HALT-MS program explores how diet, exercise and psychology can help support self-management of multiple sclerosis As ...

Aureus School in Didcot has chosen the MSA Trust as its charity of the year in honour of former assistant headteacher Carolyn Saul, who ...

Calum Richardson revealed earlier this year that watching his older sister Karen battle multiple sclerosis made him realise ...

Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...

Testing showed that Gonzalez’ ALS was caused by a mutation in the SOD1 gene (Super Oxide Dismutase 1), which meant she was eligible for a relatively new, FDA-approved medication called Qalsody.

The research team was led by Dr. Matthew Brier, a neurologist and radiologist. He explained that something about the biology ...

Biogen Inc. ( BIIB) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Good morning. My name is Cynthia, and I will be your conference operator today. At this time, I would like to welcome everyone to ...